Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients - Inserm - Institut national de la santé et de la recherche médicale
Conference Papers Year : 2015

Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients

Sophie Le Lamer
  • Function : Author
  • PersonId : 952774
Bertrand Audoin
  • Function : Author
  • PersonId : 959321
Adil Maarouf
Christophe Portefaix
Laurent Pierot
  • Function : Author
  • PersonId : 931409
Valerie Cuvier
  • Function : Author
Julien Veys
  • Function : Author
Rebecca Pruss
  • Function : Author
Wilfried Hauke
  • Function : Author
No file

Dates and versions

inserm-01244547 , version 1 (15-12-2015)

Identifiers

  • HAL Id : inserm-01244547 , version 1

Cite

Jean Pelletier, Jean-Philippe Ranjeva, Ayman Tourbah, Gilles Edan, Christian Barillot, et al.. Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients. American Academy of Neurology, Apr 2015, Washington, DC, United States. ⟨inserm-01244547⟩
380 View
0 Download

Share

More